Claritas Rx Vice President of Product Meghna Misra is featured in the BioXconomy article, “Patient abandonment crisis persists despite industry’s data revolution,” a candid assessment of why a decade of investment in data infrastructure hasn’t translated into meaningfully better patient outcomes, and what it will actually take to close that gap.
At a Glance
- A decade of data infrastructure investment was designed for operational reporting, leaving patient-centered decision-making behind.
- Patient abandonment starts long before a patient drops off, with prior auth delays, expiring copay cards, and gaps in accountability across hubs and specialty pharmacies.
- AI initiatives in patient services fail when they’re treated as innovation projects rather than operational ones, producing dashboards nobody looks at instead of workflows teams actually use.
The article explores the cultural and structural shifts required to move patient services teams from reactive reporting to proactive intervention, and why the organizations making real progress share one common trait: leadership that treats patient outcomes as a measurable, accountable priority, not just a value statement. Misra also addresses the often-overlooked consent problem sitting underneath most AI ambitions in patient services, and what genuine personalization at scale could look like for manufacturers willing to invest in the infrastructure to make it real.
